General Information of the Compound
| Compound ID |
CP0484703
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[4-[4-(5-chloro-2-methoxyphenyl)piperazin-1-yl]butyl]-4-methyl-4-phenylpiperidine-2,6-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H34ClN3O3
|
||||||||||||||||||
| Molecular Weight |
484.04
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(CC2=O)c2ccccc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H34ClN3O3/c1-27(21-8-4-3-5-9-21)19-25(32)31(26(33)20-27)13-7-6-12-29-14-16-30(17-15-29)23-18-22(28)10-11-24(23)34-2/h3-5,8-11,18H,6-7,12-17,19-20H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
SMDCOYCKERWTAT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor